ipratropium bromide 0.2 MG/ML Inhalation Solution

What the CMS Formulary Data Shows for ipratropium bromide 0.2 MG/ML Inhalation Solution

Per the CMS 2026 Part D formulary file, ipratropium bromide 0.2 MG/ML Inhalation Solution (RxNorm concept RXCUI 836358, generic name ipratropium bromide) appears on 328 distinct formulary files spanning 5,052 Medicare Part D plan offerings - 100% of enrollable Part D products, near-universal placement. Tier placement ranges from Tier 1 to Tier 3, with a cross-plan average of Tier 1.8.

Real-world access to ipratropium bromide 0.2 MG/ML Inhalation Solution depends on utilization management as much as tier placement: 99.7% of covering formularies require prior authorization. 0% require step therapy. 10.1% apply quantity limits.

Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 743,544 Part D beneficiaries filled ipratropium bromide 0.2 MG/ML Inhalation Solution in 2023, with total plan-and-beneficiary spending of $77,483,714 and an average per-beneficiary annual cost of $104.21. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry ipratropium bromide 0.2 MG/ML Inhalation Solution today.